Correlation Between Bristol Myers and Dividend
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Dividend at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Dividend into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Dividend 15 Split, you can compare the effects of market volatilities on Bristol Myers and Dividend and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Dividend. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Dividend.
Diversification Opportunities for Bristol Myers and Dividend
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Bristol and Dividend is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Dividend 15 Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dividend 15 Split and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Dividend. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dividend 15 Split has no effect on the direction of Bristol Myers i.e., Bristol Myers and Dividend go up and down completely randomly.
Pair Corralation between Bristol Myers and Dividend
Assuming the 90 days horizon Bristol Myers Squibb is expected to under-perform the Dividend. In addition to that, Bristol Myers is 3.64 times more volatile than Dividend 15 Split. It trades about 0.0 of its total potential returns per unit of risk. Dividend 15 Split is currently generating about 0.21 per unit of volatility. If you would invest 348.00 in Dividend 15 Split on September 21, 2024 and sell it today you would earn a total of 10.00 from holding Dividend 15 Split or generate 2.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.65% |
Values | Daily Returns |
Bristol Myers Squibb vs. Dividend 15 Split
Performance |
Timeline |
Bristol Myers Squibb |
Dividend 15 Split |
Bristol Myers and Dividend Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bristol Myers and Dividend
The main advantage of trading using opposite Bristol Myers and Dividend positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Dividend can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dividend will offset losses from the drop in Dividend's long position.Bristol Myers vs. Novartis AG | Bristol Myers vs. Bayer AG | Bristol Myers vs. Astellas Pharma | Bristol Myers vs. Roche Holding AG |
Dividend vs. Copa Holdings SA | Dividend vs. United Airlines Holdings | Dividend vs. Delta Air Lines | Dividend vs. SkyWest |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |